HKSE:00570 (Hong Kong)
Â
Ordinary Shares
HK$
4.28
(0%)
May 21
Current and historical daily PE Ratio for China Traditional Chinese Medicine Holdings Co Ltd (
HKSE:00570
) from 1993 to May 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. China Traditional Chinese Medicine stock (HKSE:00570) PE ratio as of May 21 2024 is 15.3.
More Details
China Traditional Chinese Medicine Holdings Co Ltd (HKSE:00570) PE Ratio (TTM) Chart
China Traditional Chinese Medicine Holdings Co Ltd (HKSE:00570) PE Ratio (TTM) Historical Data
View and export this data going back to 1993. Start your Free Trial
Total 1209
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| China Traditional Chinese Medicine PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-21 | 15.3 | 2024-03-13 | 15.5 |
| 2024-05-21 | 15.3 | 2024-03-12 | 15.5 |
| 2024-05-20 | 15.3 | 2024-03-11 | 15.4 |
| 2024-05-17 | 15.3 | 2024-03-08 | 15.5 |
| 2024-05-16 | 15.3 | 2024-03-07 | 15.5 |
| 2024-05-14 | 15.4 | 2024-03-06 | 15.5 |
| 2024-05-13 | 15.4 | 2024-03-05 | 15.4 |
| 2024-05-10 | 15.4 | 2024-03-04 | 15.6 |
| 2024-05-09 | 15.4 | 2024-03-01 | 15.6 |
| 2024-05-08 | 15.4 | 2024-02-29 | 15.5 |
| 2024-05-07 | 15.4 | 2024-02-28 | 15.5 |
| 2024-05-06 | 15.4 | 2024-02-27 | 15.5 |
| 2024-05-03 | 15.4 | 2024-02-26 | 15.5 |
| 2024-05-02 | 15.4 | 2024-02-23 | 15.4 |
| 2024-04-30 | 15.3 | 2024-02-22 | 15.3 |
| 2024-04-29 | 15.4 | 2024-02-21 | 12.3 |
| 2024-04-26 | 15.4 | 2024-02-20 | 12.3 |
| 2024-04-25 | 15.5 | 2024-02-19 | 12.3 |
| 2024-04-24 | 15.5 | 2024-02-16 | 12.3 |
| 2024-04-23 | 15.5 | 2024-02-15 | 12.3 |
| 2024-04-22 | 15.5 | 2024-02-14 | 12.3 |
| 2024-04-19 | 15.5 | 2024-02-09 | 12.3 |
| 2024-04-18 | 15.4 | 2024-02-08 | 12.3 |
| 2024-04-17 | 15.5 | 2024-02-07 | 12.3 |
| 2024-04-16 | 15.5 | 2024-02-06 | 11.2 |
| 2024-04-15 | 15.5 | 2024-02-05 | 10.4 |
| 2024-04-12 | 15.5 | 2024-02-02 | 10.4 |
| 2024-04-11 | 15.5 | 2024-02-01 | 10.7 |
| 2024-04-10 | 15.5 | 2024-01-31 | 10.7 |
| 2024-04-09 | 15.5 | 2024-01-30 | 10.8 |
| 2024-04-08 | 15.4 | 2024-01-29 | 11.1 |
| 2024-04-05 | 15.5 | 2024-01-26 | 10.8 |
| 2024-04-03 | 15.5 | 2024-01-25 | 10.9 |
| 2024-04-02 | 15.5 | 2024-01-24 | 10.7 |
| 2024-03-28 | 15.3 | 2024-01-23 | 10.4 |
| 2024-03-27 | 15.4 | 2024-01-22 | 10.3 |
| 2024-03-26 | 15.4 | 2024-01-19 | 10.7 |
| 2024-03-25 | 15.4 | 2024-01-18 | 10.9 |
| 2024-03-22 | 15.5 | 2024-01-17 | 11.2 |
| 2024-03-21 | 15.6 | 2024-01-16 | 11.5 |
| 2024-03-20 | 15.4 | 2024-01-15 | 11.8 |
| 2024-03-19 | 15.4 | 2024-01-12 | 11.7 |
| 2024-03-18 | 15.6 | 2024-01-11 | 12.0 |
| 2024-03-15 | 15.5 | 2024-01-10 | 12.0 |
| 2024-03-14 | 15.4 | 2024-01-09 | 12.0 |
China Traditional Chinese Medicine Holdings Co Ltd (HKSE:00570) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
China Traditional Chinese Medicine Holdings Co Ltd
ISIN : HK0000056256
Share Class Description:
HKSE:00570: Ordinary SharesCompare
Compare
Traded in other countries / regions
00570.Hong KongWSG.GermanyCHIZF.USA IPO Date
1993-07-04Description
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. It generates maximum revenue from the Yifang segment which mainly engages in the manufacture and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces under the Yi Fang brand. The majority of the revenue of the Yi Fang segment is derived from the sales of CTCMG. Geographically, it derives a majority of its revenue from Mainland China.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers